Revolutionizing MRI
Contrast Agents for Disease
Detection and Tracking

Current cancer and disease detection methods are unable to detect early-stage disease progression, reducing the likelihood of early treatment and interventions. With conventional methods being used today, many patients are only detected when it is almost too late.

With InLighta BioSciences, the hope of easier and earlier detection is a reality.
InLighta BioSciences offers precision Magnetic Resonance Imaging (pMRI) technology that addresses current deficiencies in other medical diagnostics making it possible for true early disease detection, faster monitoring disease progression, clearer opportunities to utilize image-guided intervention, and dramatically more effective evaluating drug delivery and therapeutic treatment.